Make Informed Decisions with Alignment Healthcare Inc (ALHC) Stock Updates

In the past week, ALHC stock has gone down by -2.09%, with a monthly decline of -3.43% and a quarterly surge of 9.74%. The volatility ratio for the week is 4.28%, and the volatility levels for the last 30 days are 4.04% for Alignment Healthcare Inc The simple moving average for the past 20 days is -4.81% for ALHC’s stock, with a 33.99% simple moving average for the past 200 days.

Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?

Company’s 36-month beta value is 1.50.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”

The public float for ALHC is 109.48M, and currently, short sellers hold a 7.36% ratio of that floaft. The average trading volume of ALHC on February 20, 2025 was 1.75M shares.

ALHC) stock’s latest price update

Alignment Healthcare Inc (NASDAQ: ALHC)’s stock price has increased by 2.03 compared to its previous closing price of 13.80. However, the company has seen a -2.09% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-06 that ORANGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2024 financial results on Thursday, Feb. 27, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST.

Analysts’ Opinion of ALHC

Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.

BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.

ALHC Trading at 8.19% from the 50-Day Moving Average

After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.00% of loss for the given period.

Volatility was left at 4.04%, however, over the last 30 days, the volatility rate increased by 4.28%, as shares sank -3.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.46% upper at present.

During the last 5 trading sessions, ALHC fell by -2.09%, which changed the moving average for the period of 200-days by +169.73% in comparison to the 20-day moving average, which settled at $14.79. In addition, Alignment Healthcare Inc saw 25.16% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALHC starting from Wagner Andreas P., who sale 14,878 shares at the price of $14.38 back on Feb 12 ’25. After this action, Wagner Andreas P. now owns 200,885 shares of Alignment Healthcare Inc, valued at $213,946 using the latest closing price.

KAO JOHN E, the Chief Executive Officer of Alignment Healthcare Inc, sale 90,000 shares at $14.23 during a trade that took place back on Feb 11 ’25, which means that KAO JOHN E is holding 2,183,100 shares at $1,280,304 based on the most recent closing price.

Stock Fundamentals for ALHC

Current profitability levels for the company are sitting at:

  • -0.05 for the present operating margin
  • 0.1 for the gross margin

The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.

Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.65. The debt to equity ratio resting at 1.92. The interest coverage ratio of the stock is -5.14.

Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 1.05. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.

Conclusion

In a nutshell, Alignment Healthcare Inc (ALHC) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts